Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Goodkin

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|November 20, 1998
Interferon beta therapy for multiple sclerosisD E Goodkin
Neurology|February 1, 1991
EDSS reliabilityD E Goodkin
Lancet (London, England)|October 15, 1994
Interferon beta-1bD E Goodkin
Lancet (London, England)|December 17, 1994
Interferon beta-1bD E Goodkin
The Western Journal of Medicine|September 1, 1994
Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosisD E Goodkin
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
MS clinical trial design for the futureD E Goodkin
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
Interferon beta treatment for multiple sclerosis: persisting questionsD E Goodkin
Archives of Neurology|September 1, 1989
Seasonal variation of multiple sclerosis exacerbations in North DakotaD E Goodkin, D Hertsgaard
Drugs|April 25, 2000
Drugs used to treat spasticityM Kita, D E Goodkin
Neurology|January 1, 1994
Ethical considerations raised by the approval of interferon beta-1b for the treatment of multiple sclerosisD E Goodkin, G A Kanoti
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|November 20, 1998
Interferon beta therapy for multiple sclerosisD E Goodkin
Neurology|February 1, 1991
EDSS reliabilityD E Goodkin
Lancet (London, England)|October 15, 1994
Interferon beta-1bD E Goodkin
Lancet (London, England)|December 17, 1994
Interferon beta-1bD E Goodkin
The Western Journal of Medicine|September 1, 1994
Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosisD E Goodkin
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
MS clinical trial design for the futureD E Goodkin
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
Interferon beta treatment for multiple sclerosis: persisting questionsD E Goodkin
Archives of Neurology|September 1, 1989
Seasonal variation of multiple sclerosis exacerbations in North DakotaD E Goodkin, D Hertsgaard
Drugs|April 25, 2000
Drugs used to treat spasticityM Kita, D E Goodkin
Neurology|January 1, 1994
Ethical considerations raised by the approval of interferon beta-1b for the treatment of multiple sclerosisD E Goodkin, G A Kanoti
Pageof 9